AzTrials
AzTrials

Ventilation Therapy; ComplicationsNCT05726877

Optimal PEEP in Pediatric Patients Under 17 Years of Age.

A study testing ventilation strategy in people with Ventilation Therapy; Complications, run by Seoul National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aimed to investigate the differences in positive end-expiratory pressure titration in the supine and prone positions by age in pediatric patients under 17 years of age who received general anesthesia and then evaluate the hemodynamic stability. Read more about this study

Who is it for?
Ages 0 to 16 years
Conditions the study is for
Ventilation Therapy; Complications
What is being tested?
ventilation strategy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteSouth Korea
Study dates
17 Oct 2022to 31 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • patients who are scheduled to undergo general anesthesia in the prone position
  • patients who are in age under 17 years

Who cannot join

  • had cyanosis or chronic respiratory failure
  • had respiratory distress syndrome or bronchopulmonary dysplasia
  • had laryngotracheal diseases
  • had pulmonary hypertension
  • receiving oxygen therapy

Trial locations and contacts

1 site in 1 country.

Hee-Soo Kim, M.D., Ph.D. contact

02-2072-3664

dami0605@snu.ac.kr

South Korea1 site, 1 recruiting
  • Seoul National University Hospital

    Seoul

    Hee-Soo Kim, M.D.,Ph.D., 02-2072-3664, dami0605@snu.ac.kr

    Recruiting

Other trials in South Korea

About this study

Official title: Determination of Optimal Positive End-expiratory Pressure in Prone Position During General Anesthesia Using Electrical Impedance Tomography in Pediatric Patient Under 17 Years of Age

This study aimed to investigate the differences in positive end-expiratory pressure titration in the supine and prone positions by age in pediatric patients under 17 years of age who received general anesthesia and then evaluate the hemodynamic stability.

Being tested
ventilation strategy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ventilation strategyOther

    Titrating positive end-expiratory pressure

Study groups in NCT05726877
Study groupRoleWhat they receive
Experimental armExperimentalAll patients will be enrolled in the same arm.
Receives: Other: ventilation strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Optimal positive end-expiratory pressure (PEEP)

    result of decremental PEEP trial

    Measured: 10 minutes after intubation

  2. Optimal positive end-expiratory pressure (PEEP)

    result of decremental PEEP trial

    Measured: 60 minutes after prone positioning

Secondary outcomes (21)
  1. Impedance tidal variation

    respiratory parameters measured by Electrical Impedance Tomography (EIT) device

    Measured: 10 minutes after intubation

  2. Impedance tidal variation

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  3. regional respiratory system compliance

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  4. regional respiratory system compliance

    respiratory parameters measured by EIT device

    Measured: 10 minutes after intubation

  5. overdistension or atelectasis

    respiratory parameters measured by EIT device

    Measured: 10 minutes after intubation

  6. overdistension or atelectasis

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  7. end-expiratory lung volume

    respiratory parameters measured by EIT device

    Measured: 10 minutes after intubation

  8. end-expiratory lung volume

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  9. end-expiratory lung impedance

    respiratory parameters measured by EIT device

    Measured: 10 minutes after intubation

  10. end-expiratory lung impedance

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  11. regional ventilation delay

    respiratory parameters measured by EIT device

    Measured: 10 minutes after intubation

  12. regional ventilation delay

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  13. center of ventilation

    respiratory parameters measured by EIT device

    Measured: 10 minutes after intubation

  14. center of ventilation

    respiratory parameters measured by EIT device

    Measured: 60 minutes after prone positioning

  15. vital signs

    blood pressure (mmHg)

    Measured: 10 minutes after intubation

  16. vital signs

    blood pressure (mmHg)

    Measured: 60 minutes after prone positioning

  17. vital signs

    oxygen saturation (%)

    Measured: 10 minutes after intubation

  18. vital signs

    oxygen saturation (%)

    Measured: 60 minutes after prone positioning

  19. vital signs

    heart rate (BPM)

    Measured: 10 minutes after intubation

  20. vital signs

    heart rate (BPM)

    Measured: 60 minutes after prone positioning

  21. arterial blood gas analysis, if patients has arterial catheter

    oxygen and cardon dioxide tension

    Measured: 10 minutes after intubation & 60 minutes after prone positioning

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2023
  2. Study start17 Oct 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
51 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05726877
Sponsor's protocol ID
2208-091-1351
Status last verified
Jan 2023
First submitted
6 Jan 2023
Last updated
14 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ventilation strategy in people with Ventilation Therapy; Complications, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hee-Soo Kim, M.D., Ph.D. (02-2072-3664, dami0605@snu.ac.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Optimal positive end-expiratory pressure (PEEP) (time frame: 10 minutes after intubation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in